Preliminary evaluation of hetacillin in the treatment of acute bacterial meningitis.
D000208:Acute Disease; D000284:Administration, Oral; D000469:Alkaline Phosphatase / Q000097:blood; D001769:Blood / Q000382:microbiology; D001925:Brain Damage, Chronic; D002555:Cerebrospinal Fluid / Q000382:microbiology; D002675:Child, Preschool; D005260:Female; D005334:Fever; D006193:Haemophilus influenzae / Q000302:isolation & purification; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D007223:Infant; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008297:Male; D008581:Meningitis / Q000150:complications / Q000188:drug therapy*; D008583:Meningitis, Haemophilus / Q000188:drug therapy; D008585:Meningitis, Meningococcal / Q000188:drug therapy; D008586:Meningitis, Pneumococcal / Q000188:drug therapy; D009305:Nasopharynx / Q000382:microbiology; D009345:Neisseria meningitidis / Q000302:isolation & purification; D010406:Penicillins / Q000008:administration & dosage / Q000627:therapeutic use*; D013296:Streptococcus pneumoniae / Q000302:isolation & purification; D013997:Time Factors; D014581:Urticaria
D007093:Imidazoles; D010406:Penicillins; D000469:Alkaline Phosphatase